Clinical Studies

The Clinical Trial Unitconducted a record number of clinical trials, many of them part of national and international collaborative studies. In particular, the group are involved in exciting studies involving novel therapies in the treatment of chronic myeloid leukaemia, multiple myeloma and myelodysplastic syndromes.

Actively recruiting:

Acute Myeloid Leukaemia

AML Decitabine
AML M12
AML M13
APML4

Chronic Myeloid Leukaemia

CML7 – Glivec with Pegylated Interferon
CML8 – Cessation of Glivec
CML TOPS - 400 vs 800mg Glivec
CML ALL1
CML ALL AMN107 – Nilotinib
Glivec INDY-CML and other diseases thought to be responsive to a tyrosine kinase inhibitor

Myeloma

MM1195 DT-PACE
MM Denosemab
MM Velcade BIR
Mucositis WHEY

Lymphoma

HD04
NHL 11-Hyper C-VAD
NHL 13 - CORAL
NHL – Prima
NHL – Velcade

Transplant

Transplant – Double Cord
Transplant – Mesenchymal Stem Cells
MBL polymorphism

Haemostasis

VWD Biostate

Ongoing but closed to recruitment:

Acute Myeloid Leukaemia

AML M11
APML3 ATRA

Chronic Lymphocytic Leukaemia

CLL2

Chronic Myeloid Leukaemia

CML4
CML5
CML6
BMS 006
BMS 013
BMS 034
BMS 035
CML IRIS

Iron Overload

Myeloma

MM6
MM Velcade/Doxil
MM Vista

Lymphoma

HD3
NHL Follicular, EBMT
NHL LOW4
NHL Mantle Cell, LY05

Transplant

ALLO Valacyclovir